Related Experiment Video
Updated: Nov 18, 2025
05:00
Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
Published on: April 1, 2019
15.4K
Effect of IPL in Patients with Meibomian Gland Dysfunction
Anna Schuh1, Daniel Muth1, Mehdi Shajari1
1Department of Ophthalmology, Ludwig-Maximilians-University, München, Germany.
Klinische Monatsblatter Fur Augenheilkunde
|February 4, 2021
Summary
Intense pulsed light (IPL) therapy significantly improves symptoms and clinical signs of meibomian gland dysfunction (MGD). This safe and effective treatment offers a valuable supportive option for MGD patients.
Area of Science:
- Ophthalmology
- Dermatology
- Medical Technology
Background:
- Meibomian gland dysfunction (MGD) is a common condition affecting the ocular surface.
- MGD leads to discomfort and visual disturbances due to impaired lipid layer of the tear film.
Purpose of the Study:
- To evaluate the efficacy and safety of intense pulsed light (IPL) treatment for patients diagnosed with MGD.
Main Methods:
- A retrospective analysis was conducted on 25 MGD patients treated with IPL.
- Data collected included demographics, clinical findings (eyelid vascularization, meibomian gland status, tear film break-up time, corneal staining), and patient-reported outcomes (OSDI).
- Assessments were performed at baseline and at multiple follow-up points post-treatment.
Main Results:
- IPL treatment resulted in significant improvements in tear film break-up time, corneal staining, conjunctival redness, and meibomian gland function.
- Patient-reported Ocular Surface Disease Index (OSDI) scores also showed significant reduction.
- Improvements were observed even after the first IPL session, with no significant adverse effects reported.
Conclusions:
- Intense pulsed light (IPL) is a safe and effective therapeutic option for managing meibomian gland dysfunction (MGD).
- IPL can be utilized as an effective supportive treatment to alleviate MGD symptoms and signs.
